Press Release: Highlander Partners Portfolio Company, Signal Path, Acquired by Verily
Press Release: Highlander Partners Portfolio Company, Signal Path, Acquired by Verily
Press Release: Highlander Partners Portfolio Company, Signal Path, Acquired by Verily
新聞稿：Highlander Partners Portfolio Company，Signal Path，被Verely收購
Highlander Partners Portfolio Company, Signal Path, Acquired by Verily
Highlander Partners Portfolio Company，Signal Path，被Verely收購
PR Newswire
美通社
SOUTH SAN FRANCISCO, Calif. & RALEIGH, N.C, Aug. 31, 2021
加利福尼亞州南舊金山北卡羅來納州羅利，2021年8月31日
SOUTH SAN FRANCISCO, Calif. & RALEIGH, N.C, Aug. 31, 2021 /PRNewswire/ -- SignalPath, a Raleigh NC-based portfolio company of Highlander Partners, has been acquired by Verily, an Alphabet company. SignalPath was founded in 2014 with the financial support of Highlander Partners to change the way that clinical research is conducted, with a specific focus on building a state-of-the-art software platform to improve the ease and efficiency of clinical trial execution at research sites.
加利福尼亞州南舊金山北卡羅來納州羅利，2021年8月31日電Highlander Partners公司位於北卡羅來納州羅利的投資組合公司SignalPath已被Alphabet公司Verely收購。SignalPath成立於2014年，由Highlander Partners提供資金支持，旨在改變臨牀研究的進行方式，專門致力於構建最先進的軟件平台，以提高研究地點臨牀試驗執行的簡易性和效率。
SignalPath's platform reduces fragmentation by providing a modern, intuitive software application with which to optimize management of a health system's clinical trials portfolio. SignalPath's robust technology infrastructure offers novel solutions to partners that can dramatically improve the costs, complexities and time associated with clinical trials. By joining Verily, SignalPath will be able to provide clinical research sites access to a quickly growing portfolio of resources, tools and trial opportunities that further strengthen its value proposition.
SignalPath的平台通過提供現代、直觀的軟件應用程序來優化醫療系統臨牀試驗組合的管理，從而減少了碎片化。SignalPath強大的技術基礎設施為合作伙伴提供了新穎的解決方案，可以極大地降低與臨牀試驗相關的成本、複雜性和時間。通過加入Verely，SignalPath將能夠為臨牀研究網站提供快速增長的資源、工具和試驗機會組合，這些資源、工具和試驗機會進一步加強了它的價值主張。
"At SignalPath, we've created a better research ecosystem - one that combines a network of premier, technology-enabled research sites with a best-in-class suite of clinical trial tools to address the pain points experienced by patients, sites and sponsors," said Brad Hirsch, MD, a Senior Advisor to Highlander Partners and Co-Founder and Chief Executive Officer of SignalPath. "Combining these capabilities with Verily's clinical studies platforms business accelerates our ability to scale these solutions and make them available to a larger group of sites as well as provide entirely new opportunities to our network. It is another step forward in accelerating clinical research and helping get treatments to market faster."
Highlander Partners高級顧問、SignalPath聯合創始人兼首席執行官布拉德·赫希醫學博士説：“在SignalPath，我們創造了一個更好的研究生態系統--它將一流的技術驅動的研究網站網絡與一流的臨牀試驗工具套件結合在一起，以解決患者、網站和贊助商所經歷的痛點。”布拉德·赫希是Highlander Partners的高級顧問，也是SignalPath的聯合創始人兼首席執行官。將這些能力與Verely公司的臨牀研究平台業務相結合，加快了我們擴大這些解決方案的能力，使它們可供更多的網站使用，併為我們的網絡提供了全新的機會。這是在加速臨牀研究和幫助將療法更快推向市場方面向前邁出的又一步。“
SignalPath employees will join Verily as part of Verily's clinical research business at the time of closing. They will maintain their physical presence in Raleigh, increasing Verily's geographic footprint with this new location in North Carolina.
SignalPath的員工將在交易結束時加入Verely公司，作為其臨牀研究業務的一部分。他們將保持在羅利的實體存在，通過在北卡羅來納州的這個新地點擴大Verely的地理足跡。
About Verily
關於威利
Launched in 2015, Verily is a subsidiary of Alphabet focused on life sciences and healthcare. Verily's mission is to make the world's health data useful so that people enjoy healthier lives. Verily develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. Verily partners with leading life sciences, medical device, and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances and deployment at scale. For more information, please visit verily.com.
Verely成立於2015年，是Alphabet的子公司，專注於生命科學和醫療保健。Verely的使命是讓世界上的健康數據變得有用，這樣人們就可以享受更健康的生活。確實開發了收集、組織和激活健康數據的工具和設備，並創建了預防和管理疾病的干預措施。與領先的生命科學、醫療設備和政府組織建立真正的合作伙伴關係，利用深厚的硬件、軟件、科學和醫療保健專業知識實現更快的開發、有意義的進展和大規模部署。欲瞭解更多信息，請訪問verily.com。
About SignalPath
關於SignalPath
SignalPath was founded by Brad Hirsch, MD, and Kevin Monroe in 2014 to develop solutions to many of the challenges facing modern clinical trial management at research sites with the goal of then empowering a technology- enabled network of sites to more broadly advance the way that clinical research is conducted. The company's clinical trial management system (CTMS) was built by researchers, for researchers, to dramatically improve the ease, quality, efficiency and profitability of trial execution. The SignalPath CTMS digitizes protocols for clients, which eliminates a significant impediment to utilization, ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients. The SignalPath Research Consortium (SPARC) consists of top clinical research sites, chosen for their people, processes and track record. Through a mixture of technology solutions, training, community offerings and curated trials, SPARC sites and sponsors are able to partner to dramatically outperform competitors.
SignalPath由醫學博士布拉德·赫希(Brad Hirsch)和凱文·門羅(Kevin Monroe)於2014年創立，旨在開發解決方案，以應對研究地點現代臨牀試驗管理面臨的許多挑戰，目標是增強技術支持的地點網絡，以更廣泛地推進臨牀研究的開展方式。該公司的臨牀試驗管理系統(CTMS)是由研究人員為研究人員構建的，旨在顯著提高試驗執行的簡易性、質量、效率和盈利能力。SignalPath CTMS將客户的協議數字化，這消除了使用的一個重大障礙，確保了試驗執行的質量，提高了效率，並使現場工作人員能夠專注於患者。SignalPath研究聯盟(SPARC)由頂級臨牀研究站點組成，根據其人員、流程和記錄進行選擇。通過一系列技術解決方案、培訓、社區服務和精心策劃的試驗，SPARC網站和贊助商能夠結成合作夥伴，大幅超越競爭對手。
About Highlander Partners
關於Highlander Partners
Highlander Partners, L.P. is a Dallas-based private investment firm with over $2 billion of assets under management. The firm focuses on making investments in businesses in targeted industries in which the principals of the firm have significant operating and investing experience. Highlander Partners uses a buy and build investment approach, creating value by helping companies grow organically and through acquisitions. For more information, visit www.highlander-partners.com.
Highlander Partners，L.P.是一家總部位於達拉斯的私人投資公司，管理着超過20億美元的資產。該公司專注於對目標行業中的企業進行投資，在這些行業中，公司負責人擁有豐富的運營和投資經驗。Highlander Partners採用先買後建的投資方式，通過幫助公司實現有機增長和收購來創造價值。欲瞭解更多信息，請訪問www.Highlander-partners.com。
View original content to download multimedia:https://www.prnewswire.com/news-releases/highlander-partners-portfolio-company-signal-path-acquired-by-verily-301366716.html
查看原創內容以下載multimedia:https://www.prnewswire.com/news-releases/highlander-partners-portfolio-company-signal-path-acquired-by-verily-301366716.html
SOURCE Highlander Partners, L.P.
來源：Highlander Partners，L.P.
/Web site: http://www.highlander-partners.com
網址：http://www.highlander-partners.com
(END) Dow Jones Newswires
(完)道瓊通訊社
August 31, 2021 18:28 ET (22:28 GMT)
2021年8月31日美國東部時間18：28(格林尼治標準時間22：28)
譯文內容由第三人軟體翻譯。